Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pediatric Hematology and Oncology|April 11, 2013
Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectivesJennifer Worch, Marius Rohde, Birgit Burkhardt
BMC Health Services Research|April 3, 2023
eHealth policy framework in Low and Lower Middle-Income Countries; a PRISMA systematic review and analysisShegaw Anagaw Mengiste, Konstantinos Antypas, Marius Rohde Johannessen, et al.
Online Journal of Public Health Informatics|October 10, 2025
Cultivating Disaster Preparedness: Scoping Review of Technology's Contribution to Situational Awareness and Disaster Mindset in Disaster MedicineAmir Khorram-Manesh, Marius Rohde Johannessen, Laurits Rauer Nielsen, et al.
Frontiers in Pediatrics|March 3, 2023
Prehospital emergency medicine for children receiving palliative home care in Germany-a cross-sectional, exploratory study of EMS providersHolger Hauch, Naual El Mohaui, Vera Vaillant, et al.
Frontiers in Pediatrics|January 27, 2023
Cardiopulmonary resuscitation in pediatric patients under palliative home care - A multicenter retrospective studyEmmanuel Schneck, Gisela Janßen, Vera Vaillant, et al.
Frontiers in Medicine|February 27, 2023
Determinants of patient and physician global assessments of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitisMarius Rohde, Anna Kernder, Hasan Acar, et al.
Blood|February 12, 2013
Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescenceBettina R Bonn, Marius Rohde, Martin Zimmermann, et al.
British Journal of Haematology|March 25, 2024
Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Anke Barnbrock, Anja Möricke, Draga Barbaric, et al.
Haematologica|February 18, 2017
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocolsMarius Rohde, Bettina R Bonn, Martin Zimmermann, et al.
Immunotargets and Therapy|April 8, 2026
Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin LymphomaMarius Rohde, Vijay Kumar Singh, Andrea Wolfermann, et al.
Pageof 3